Shares of VentriPoint Diagnostics Ltd. (CVE:VPT – Get Free Report) rose 52.9% on Thursday . The company traded as high as C$0.15 and last traded at C$0.13. Approximately 2,487,387 shares traded hands during mid-day trading, an increase of 1,201% from the average daily volume of 191,210 shares. The stock had previously closed at C$0.09.
VentriPoint Diagnostics Stock Up 76.5 %
The company has a debt-to-equity ratio of -58.56, a quick ratio of 6.67 and a current ratio of 0.28. The firm has a market capitalization of C$24.33 million, a price-to-earnings ratio of -4.63 and a beta of 0.39. The business’s 50 day moving average is C$0.10 and its 200-day moving average is C$0.13.
VentriPoint Diagnostics Company Profile
Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. It offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient’s heart chambers.
See Also
- Five stocks we like better than VentriPoint Diagnostics
- What Are Growth Stocks and Investing in Them
- Volatility Is Back: 3 Stocks To Cushion the S&P 500’s Swings
- The Risks of Owning Bonds
- 2 Catalysts That Could Push NVIDIA Stock Up 30% This Year
- How to buy stock: A step-by-step guide for beginners
- Do GM Stock Buybacks Make the Stock Buyable For Investors?
Receive News & Ratings for VentriPoint Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VentriPoint Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
